Kazia Therapeutics Stock Australian S.E.
Equities
KZA
AU000000KZA9
Biotechnology & Medical Research
Sales 2022 | 10K 6.65K | Sales 2023 | 555 368.96 | Capitalization | 39.72M 26.4M |
---|---|---|---|---|---|
Net income 2022 | -24M -15.96M | Net income 2023 | -20M -13.3M | EV / Sales 2022 | 7,714 x |
Net cash position 2022 | 7.36M 4.89M | Net cash position 2023 | 3.44M 2.29M | EV / Sales 2023 | 65,355 x |
P/E ratio 2022 |
-3.27
x | P/E ratio 2023 |
-1.55
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 45.6% |
Latest transcript on Kazia Therapeutics
1st Jan change | Capi. | |
---|---|---|
+54.05% | 63.85B | |
-2.02% | 41.83B | |
+40.01% | 40.47B | |
-10.22% | 27.17B | |
+13.42% | 26.52B | |
-21.60% | 18.69B | |
+2.89% | 12.73B | |
+22.40% | 12.11B | |
+27.49% | 12.07B |